Skip to main content
HR 4200 110th Congress House

To amend the Internal Revenue Code of 1986 to provide a tax credit for medical research related to developing qualified infectious disease products.

Introduced: November 15, 2007 See on congress.gov
Taxation AntibioticsCommerceCommunicable diseasesDrug industry
More subjectsShow fewer subjects
HealthIncome taxMedical testsPharmaceutical researchPreventive medicineResearch and development tax creditScience, Technology, CommunicationsVaccinesVirus diseases
Sign in to write a letter Sign in to watch
This bill died when the 110th Congress ended
It never became law before the 110th Congress (2007–2008) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 15, 2007
Referred to the House Committee on Ways and Means.
Nov 15, 2007
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action November 15, 2007

Referred to the House Committee on Ways and Means.

 Plain-English summary Congressional Research Service

Amends the Internal Revenue Code to allow a general business tax credit for 50% of expenses paid for research and development of any qualified infectious disease product. Defines "qualified infectious disease product" as any antibiotic drug, antiviral, diagnostic test, biological product, or vaccine developed to treat, detect, prevent, or identify certain pathogens. Terminates such credit after 2012.

 Related & companion bills 1
  • S 2351 Identical bill A bill to amend the Internal Revenue Code of 1986 to provide a tax credit for medical research related to developing qu…
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Democratic 1
D
Davis, Danny K.
Illinois · Nov 15, 2007
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4200: To amend the Internal Revenue Code of 1986 to provide a tax credit for medical research related to developing qualified infectious disease products.. 110th Congress. Open America. https://openamerica.io/bill/110-HR-4200/
MLA
"H.R. 4200: To amend the Internal Revenue Code of 1986 to provide a tax credit for medical research related to developing qualified infectious disease products.." 110th Congress, 2026, Open America, https://openamerica.io/bill/110-HR-4200/.
Bluebook (legal)
H.R. 4200, 110th Cong. (2026), https://openamerica.io/bill/110-HR-4200/.
Markdown link
[H.R. 4200: To amend the Internal Revenue Code of 1986 to provide a tax credit for medical research related to developing qualified infectious disease products.](https://openamerica.io/bill/110-HR-4200/)
Report a problem